EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Peptides for Diabetic Foot Ulcers and Infections: Current Evidence and Translational Perspectives

Victoria Alexandrovna Khotina iD, Arthur Anatolievich Lee iD, Dmitry Alexandrovich Kashirskikh iD, Olesya Olegovna Klychkova iD, Vitalia Sergeevna Novikova, Margarita Pavlovna Markina, Olga Evgenevna Voronko, Vagif Ali Oglu Gasanov

International Journal of Molecular Sciences · 09.09.2026 · 27 (18) · 8035

DOI: 10.3390/ijms27188035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.09.2026. Verfasst von Victoria Alexandrovna Khotina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 119334 Moscow, Russia. Hauptthemen laut MEDLINE: Diabetic Foot, Antimicrobial Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot ulcers (DFU) are among the most severe complications of diabetes, resulting from a combination of metabolic dysregulation, vascular insufficiency, neuropathy, chronic inflammation, and impaired tissue repair, whereas diabetic foot infection (DFI) may develop within this compromised wound environment and frequently involves polymicrobial communities and biofilms. This review evaluates the mechanistic and translational basis for the use of antimicrobial peptides (AMP) in DFU and DFI, with emphasis on the diabetic wound microenvironment, polymicrobial ecology, endogenous AMP dysregulation, mechanisms of action, therapeutic development, and barriers to clinical translation. Hyperglycemia, ischemia, oxidative and proteolytic stress, and impaired innate immunity sustain inflammation, delay tissue repair, and promote microbial persistence. These conditions may also complicate antibiotic treatment through impaired tissue exposure and biofilm-associated tolerance. Depending on the peptide and experimental context, AMP may provide direct antimicrobial or antibiofilm activity and may also exert immunomodulatory or pro-reparative effects involving inflammatory signaling, angiogenesis, keratinocyte and fibroblast migration, and re-epithelialization. Approaches under investigation include engineered peptides, combination regimens, and local biomaterial-based platforms, including hydrogels, dressings, scaffolds, and nanoparticle-conjugated systems. Clinical translation remains constrained by proteolytic instability, potential host-tissue toxicity, limited selectivity, limited predictive value of preclinical models, heterogeneous clinical populations, nonstandardized endpoints, and manufacturing and regulatory requirements. Preclinical evidence supports further evaluation of approaches for local delivery of AMP, whereas clinical evidence in DFU and DFI remains limited and heterogeneous, with no AMP-based intervention yet demonstrating sufficiently consistent clinical benefit to support routine use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootAntimicrobial PeptidesHumansAnimalsWound HealingBiofilmsTranslational Research, Biomedical

Stichwörter der Autor:innen

antimicrobial peptidesbiofilmdiabetic foot infectiondiabetic foot ulcerwound healingwound-targeted delivery

Substanzen

Antimicrobial Peptides

Autor:innen und Institutionen

  • Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 119334 Moscow, Russia.

ORCID-Profile: Victoria Alexandrovna Khotina, Arthur Anatolievich Lee, Dmitry Alexandrovich Kashirskikh, Olesya Olegovna Klychkova

Förderung

  • The Ministry of Education and Science of the Russian Federation

Zitieren

APA

Khotina, V. A., Lee, A. A., Kashirskikh, D. A., Klychkova, O. O., Novikova, V. S., Markina, M. P., Voronko, O. E., & Gasanov, V. A. O. (2026). Antimicrobial Peptides for Diabetic Foot Ulcers and Infections: Current Evidence and Translational Perspectives. International Journal of Molecular Sciences, 27(18), 8035. https://doi.org/10.3390/ijms27188035

Vancouver

Khotina VA, Lee AA, Kashirskikh DA, Klychkova OO, Novikova VS, Markina MP, et al. Antimicrobial Peptides for Diabetic Foot Ulcers and Infections: Current Evidence and Translational Perspectives. International Journal of Molecular Sciences. 2026;27(18):8035. doi:10.3390/ijms27188035

BibTeX
@article{Khotina2026,
  author = {Khotina, Victoria Alexandrovna and Lee, Arthur Anatolievich and Kashirskikh, Dmitry Alexandrovich and Klychkova, Olesya Olegovna and Novikova, Vitalia Sergeevna and Markina, Margarita Pavlovna and Voronko, Olga Evgenevna and Gasanov, Vagif Ali Oglu},
  title = {Antimicrobial Peptides for Diabetic Foot Ulcers and Infections: Current Evidence and Translational Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {18},
  pages = {8035},
  doi = {10.3390/ijms27188035}
}
Kostenlos starten →